Slow-release Clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 1001-1007

  Österman, Thua ^a   Virtamo, T ^a   Lauren L ^a   Kippo, K ^a   Pasanen, I ^a   Hannuniemi, R ^a   Vaananen K ^b   Sellman, R ^a  

^a Biomed Research Center Leiras Oy   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM SALT; CLODRONIC ACID; OSTEOCALCIN;

ADJUVANT ARTHRITIS; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; HISTOPATHOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OSTEOPENIA; PAW EDEMA; PRIORITY JOURNAL; PROPHYLAXIS; RAT; SLOW DRUG RELEASE;

ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; CLODRONIC ACID; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; INFLAMMATION; INJECTIONS, INTRAVENOUS; MALE; OSTEOCALCIN; RATS; RATS, INBRED LEW;

EID: 0030894531     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BONNET, J., ZERATH, E., PICAUD, N., LESUR, C., MATTIO, A., TORDJMAN, C., HOTT, M. AND MARIE, P. J.: Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: Evidence for an early bone formation defect. J. Bone Miner. Res. 8: 659-668, 1993.
2. CAMILLERI, J. P., WILLIAMS, A. S., AMOS, N., DOUGLAS-JONES, A. G., LOVE, W. G. AND WILLIAMS, B. D.: Methods for assessing splenic macrophage depletion by liposome encapsulated clodronate. Inflamm. Res. 44: 152-157, 1995.
3. CONRAD, K. A. AND LEE, S. M.: Clodronate kinetics and dynamics. Clin. Pharmacol. Ther. 30: 114-120, 1981.
4. FLORA, L.: Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis. Arthritis Rheum. 22: 340-346, 1979.
5. FRANCIS, M. D., HOVANCIK, K. AND BOYCE, R. W.: NE-58095: A diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis. Int. J. Tissue React. XI: 239-252, 1989.
6. JEE, W. S. S., LI, X. J., KE, H. Z., LI, M., SMITH, R. J. AND DUNN, C. J.: Application of computer-based histomorphometry to the quantitative analysis of methylprednisolone-treated adjuvant arthritis in rats. Bone Miner. 22: 221-247, 1993.
7. JOFFE, I. AND EPSTEIN, S.: Osteoporosis associated with rheumatoid arthritis: Pathogenesis and management. Semin. Arthritis Rheum. 20: 256-272, 1991.
8. KALU, D. N.: The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15: 175-192, 1991.
9. KINNE, R. W., SCHMIDT-WEBER, C. B., HOPPE, R., BUCHNER, E., PALOMBO-KINNE, E., NURNBERG, E. AND EMMRICH, F.: Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes. Arthritis Rheum. 38: 1777-1790, 1995.
10. LANGMAN, C. B., FORD, K. K., PACHMAN, L. M. AND GLORIEUX, F.: Vitamin D metabolism in rats with adjuvant-induced arthritis. J. Bone Miner. Res. 5: 905-913, 1990.
11. LAURÉN, L., OSTERMAN, T. AND KARHI, T.: Pharmacokinetics of clodronate after single intravenous, intramuscular and subcutaneous injections in rats. Pharmacol. Toxicol. 69: 365-368, 1991.
12. MÖNKKÖNEN, J., VAN ROOIJEN, N. AND YLITALO, P.: Effects of clodronate and pamidronate on splenic and hepatic phagocytic cells of mice. Pharmacol. Toxicol, 68: 284-286, 1991.
13. NUGENT, R. A., MURPHY, M., SCHLACHTER, S. T., DUNN, C. J., SMITH, R. J., STAITE, N. D., GALINET, L. A., SHIELDS, S. K., ASPAR, D. G., RICHARD, K. A. AND ROHLOFF, N. A.: Pyrazoline bisphosphonate esters as novel antiinflammatory and antiarthritic agents. J. Med. Chem. 36: 134-139, 1993.
14. ÖSTERMAN, T., JUHAKOSKI, A., LAURÉN, L. AND SELLMAN, R.: Effect of iron on the absorption and distribution of clodronate after oral administration in rats. Pharmacol. Toxicol. 74: 267-270, 1994b.
15. ÖSTERMAN, T., KIPPO, K., LAURÉN, L., HANNUNIEMI, R. AND SELLMAN, R.: Effect of clodronate on established adjuvant arthritis. Rheumatol. Int. 14: 139-147, 1994a.
16. ÖSTERMAN, T., KIPPO, K., LAURÉN, L., HANNUNIEMI, R. AND SELLMAN, R.: Effect of clodronate on established collagen-induced arthritis in rats. Inflamm. Res. 44: 258-263, 1995.
17. OSTOVIC, D. AND BRENNER, G.: Development of subcutaneous and intramuscular formulations of calcium alendronate salts. Drug Dev. Ind. Pharm. 21: 1157-1169, 1995.
18. PARFITT, A. M., MATHEWS, C. H. E., VILLANEUVA, A. R., KLEEREKOPER, M., FRAME, B. AND RAO, D. S.: Relationship between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. J. Clin. Invest. 72: 1396-1409, 1983.
19. PEARSON, C. M. AND WOOD, F. D.: Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. I. General clinical and pathological characteristics and some modifying factors. Arthritis Rheum. 2: 440-459, 1959.
20. del POZO, E., GRAEBER, M., ELDFORD, P. AND PAYNE, T.: Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin A. Arthritis Rheum. 33: 247-252, 1990.
21. del POZO, E. AND ZAPF, J.: Skeletal growth and bone density as sensitive parameters in experimental arthritis: Effect of cyclosporin A. Bone 15: 625-628, 1994.
22. SAMBROOK, P. N. AND REEVE, J.: Bone disease in rheumatoid arthritis. Clin. Sci. 74: 225-230, 1988.
23. SATO, M., KIM, J., SHORT, L. L., SLEMENDA, C. W. AND BRYANT, H. U.: Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats. J. Pharmacol. Exp. Ther. 272: 1252-1259, 1995.
24. SCHENK, R. K., OLAH, A. J. AND HERRMANN, W.: Preparation of calcified tissues for light microscopy. In Methods of Calcified Tissue Preparation, ed. by G. R. Dickson, pp. 1-56. Elsevier, Amsterdam, 1984.
25. SELANDER, K. S., MÖNKKÖNEN, J., KARHUKORPI, E. K., HÄRKÖNEN, P. L., HANNUNIEMI, R. AND VÄÄNÄNEN, H. K.: Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol. Pharmacol., in press, 1996.
26. TURNER, C. H., SATO, M. AND BRYANT, H. U.: Raloxifene preserves bone strength and bone mass in ovariectomized rats. Endocrinology 135: 2001-2005, 1994.
27. YAKATAN, G. J., POYNOR, W. J., TALBERT, R. L., FLOYD, B. F., SLOUGH, C. L., AMIPULSKI, R. S. AND BENEDICT, J. J.: Clodronate kinetics and bioavailability. Clin. Pharmacol. Ther. 31: 402-410, 1982.
28. ZIMMERMANN, M.: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110, 1983.